Low dose cytarabine may prevent hematologic relapse prior to hsct in patients with AML in first complete remission with minimal residual disease Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Lindner, Sarah
  • Lang, Fabian
  • Pfeifer, Heike
  • Berg, Tobias
  • Ajib, Salem
  • Riemann, Julia
  • Jedlickova, Zuzanna
  • Gueller, Saskia
  • Toenges, Rosa
  • Steinmann, Juliane
  • Martin, Hans
  • Serve, Hubert
  • Bug, Gesine

publication date

  • July 1, 2019